DOCU analist beklentisi nötr kalmaya devam ediyor

What happened: On March 18, Citi analyst Tyler Radke downgraded DocuSign (DOCU) to 'Neutral', trimming the price target to $50 from $95. This move followed strong Q4 earnings, with EPS of $1.01, but growth outlook was deemed disappointing at 8% year-over-year. Other analysts maintained neutral ratings, adjusting price targets downwards: Piper Sandler to $52, UBS to $54.

Market impact: The bearish sentiment from Citi triggered a sell-off in DOCU, pushing its RSI into the mid-30s. The e-signature pioneer's stock price fell, impacting mid-cap software and cloud sectors. Competitors like Adobe and Microsoft may see increased scrutiny on their growth prospects.

What to watch next: DocuSign's Q1 2023 earnings on May 5 will provide insights into growth trajectory. Investors await updates on application software stocks' rebound, with DocuSign being a key indicator. Additionally, any changes in analyst ratings post-earnings will signal shifts in market sentiment.